Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Eur J Gastroenterol Hepatol

Retrieve available abstracts of 103 articles:
HTML format
Text format



Single Articles


    September 2016
  1. WIJARNPREECHA K, Thongprayoon C, Panjawatanan P, Manatsathit W, et al
    Hepatitis B virus infection and risk of gallstones: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  2. ARDESIA M, Costantino G, Fries W
    Lower response to the hepatitis B vaccine in future inflammatory bowel disease patients.
    Eur J Gastroenterol Hepatol. 2016;28:1101-2.
    PubMed     Text format    


  3. BURLONE ME, Pedrinelli AR, Giarda P, Minisini R, et al
    Influence of age on sex-related differences among patients with hepatitis C.
    Eur J Gastroenterol Hepatol. 2016;28:1100-1.
    PubMed     Text format    


    August 2016
  4. SCHULZ M, Beha D, Plehm K, Zollner C, et al
    High prevalence of anti-hepatitis E virus antibodies in outpatients with chronic liver disease in a university medical center in Germany.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  5. LEWIS H, Kunkel J, Axten D, Dalton J, et al
    Community nurse-led initiation of antiviral therapy for chronic hepatitis C in people who inject drugs does not increase uptake of or adherence to treatment.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  6. BERT F, Rindermann A, Abdelfattah MA, Stahmeyer JT, et al
    High prevalence of chronic hepatitis B and C virus infection in a population of a German metropolitan area: a prospective survey including 10 215 patients of an interdisciplinary emergency unit.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  7. PARK CH, Kim HY, Lee SW, Song DS, et al
    On-treatment and off-treatment efficacy of entecavir in a real-life cohort of chronic hepatitis B patients.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  8. MANCEBO M, Real LM, Mira JA, Recio E, et al
    Changes in the response to treatment against chronic hepatitis C between 1999 and 2015: data from a prospective cohort.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  9. DYSON JK, Jopson L, Ng S, Lowery M, et al
    Improving testing for hepatitis B before treatment with rituximab.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  10. WANG P, Huang G, Tam N, Wu C, et al
    Influence of preoperative sodium concentration on outcome of patients with hepatitis B virus cirrhosis after liver transplantation.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  11. PIERUCKA M, Stalke P, Zagozdzon P, Smiatacz T, et al
    The prevalence and co-occurrence of hematological complications at the time of diagnosis of chronic hepatitis C in Poland: a cross-sectional study.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  12. MARCELLIN F, Fournier I, Carrieri MP, Poizot-Martin I, et al
    From first-generation hepatitis C virus protease inhibitors to direct-acting antivirals: self-reported symptoms as a warning signal for potential adverse events (ANRS HC26, ANRS HC27 trials).
    Eur J Gastroenterol Hepatol. 2016;28:733-4.
    PubMed     Text format    


    May 2016
  13. KARAKOYUN M, Ecevit CO, Kilicoglu E, Aydogdu S, et al
    Autoimmune hepatitis and long-term disease course in children in Turkey, a single-center experience.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  14. MARCELLIN F, Protopopescu C, Poizot-Martin I, Miailhes P, et al
    Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort).
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  15. WANG H, Xu H, Qu L, Wang X, et al
    Red blood cell distribution width and globulin, noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  16. TOSON EA, Shiha GE, El-Mezayen HA, El-Sharkawy AM, et al
    Diagnostic performance of T lymphocyte subpopulations in assessment of liver fibrosis stages in hepatitis C virus patients: simple noninvasive score.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  17. YILMAZ B, Unlu O, Evcen R, Ugurluoglu C, et al
    Acute onset seronegative autoimmune hepatitis: are simplified diagnostic criteria sufficient?
    Eur J Gastroenterol Hepatol. 2016;28:607-8.
    PubMed     Text format    


    April 2016
  18. ZEUZEM S, Mantry P, Soriano V, Buynak RJ, et al
    Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  19. KARAGOZ E, Tanoglu A, Ulcay A, Erdem H, et al
    Mean platelet volume and red cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in patients with chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  20. LISON H, Garioud A, Halfon P, Jambon S, et al
    Cytolytic hepatitis related to simeprevir overdose in a patient with cirrhosis and HIV-HCV genotype 1 coinfection.
    Eur J Gastroenterol Hepatol. 2016;28:486-7.
    PubMed     Text format    


    March 2016
  21. GULATI R, Nawaz M, Pyrsopoulos NT
    Comparative analysis of online patient education material pertaining to hepatitis and its complications.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  22. BOTTERO J, Boyd A, Gozlan J, Carrat F, et al
    Effectiveness of hepatitis B rapid tests toward linkage-to-care: results of a randomized, multicenter study.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  23. DINTSIOS CM
    Re: Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter? (Eur J Gastroenterol Hepatol 2015, 27:1063-1068).
    Eur J Gastroenterol Hepatol. 2016;28:362.
    PubMed     Text format    


  24. OZARAS R, Tahan V, Tabak F
    More on autoimmune hepatitis and acute hepatitis A.
    Eur J Gastroenterol Hepatol. 2016;28:360.
    PubMed     Text format    


    February 2016
  25. WASZCZUK E, Waszczuk KM, Mulak A, Paradowski L, et al
    Inadequate seroprotection against hepatitis B virus and one detected case of hepatitis C virus infection among patients with inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  26. HELAL GK, Gad MA, Abd-Ellah MF, Mahgoup EM, et al
    Coadministration of ezetimibe with pegylated interferon plus ribavirin could improve early virological response in chronic hepatitis C obese Egyptian patients.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  27. CARVALHANA SC, Leitao J, Alves AC, Bourbon M, et al
    Hepatitis B and C prevalence in Portugal: disparity between the general population and high-risk groups.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  28. CORSI DJ, Karges W, Thavorn K, Crawley AM, et al
    Influence of female sex on hepatitis C virus infection progression and treatment outcomes.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


  29. NIEDERAU C, Amani A, Thiel A
    Long-term follow-up of HBsAg-positive patients in Germany.
    Eur J Gastroenterol Hepatol. 2016;28:48-56.
    PubMed     Text format     Abstract available


    December 2015
  30. HUNTER JG, Madden RG, Stone AM, Osborne N, et al
    Locally acquired hepatitis E in Cornwall, the UK; geographical clustering, environmental and social factors: a case-controlled study coastal clustering of HEV; Cornwall, UK.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  31. SELLIER PO, Schnepf N, Amarsy R, Maylin S, et al
    Hepatitis B virus status in children born to HIV/HBV coinfected women in a French hospital: a cross-sectional study.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  32. OZDEN HT
    Hepatitis A seroprevalence in patients with chronic viral hepatitis in Konya, Turkey.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  33. WANG H, Innes H, Hutchinson SJ, Goldberg DJ, et al
    The prevalence and impact of thrombocytopenia, anaemia and leucopenia on sustained virological response in patients receiving hepatitis C therapy: evidence from a large 'real world' cohort.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  34. AIZAWA Y, Abe H, Sugita T, Seki N, et al
    Centrilobular zonal necrosis as a hallmark of a distinctive subtype of autoimmune hepatitis.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  35. CHENG XP, Zhao J, Chen Y, Meng FK, et al
    Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  36. SAEZ-ROYUELA F, Linares P, Cervera LA, Almohalla C, et al
    Evaluation of advanced fibrosis measured by transient elastography after hepatitis C virus protease inhibitor-based triple therapy.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  37. ABDEL-RAZIK A, Mousa N, Abdel-Aziz M, Elhelaly R, et al
    Elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C virus genotype 4: not the end of the story.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  38. LAW ST, Lee MK, Li KK, Mok CK, et al
    Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  39. DETERDING K, Gruner N, Buggisch P, Galle PR, et al
    Symptoms of anxiety and depression are frequent in patients with acute hepatitis C and are not associated with disease severity.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  40. MARTIN DJ, Weideman R, Crook T, Brown G, et al
    Relationship of hepatic fibrosis, cirrhosis, and mortality with cholecystectomy in patients with hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  41. FEILLANT M, Jezequel C, Lison H, Delluc A, et al
    Chronic hepatitis C: treat or wait? A prospective study on reasons for treatment or nontreatment in the era of first-generation protease inhibitors.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  42. MCEWAN P, Bennett H, Ward T, Webster S, et al
    The cost-effectiveness of daclatasvir-based regimens for the treatment of hepatitis C virus genotypes 1 and 4 in the UK.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  43. PATRICIO JA JR, Lopes PF, Medeiros T, Mendes GF, et al
    Tenofovir monotherapy for hepatitis B after 1 year does not produce renal dysfunction, but is associated with hyperparathyroidism not related to vitamin D.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


    October 2015
  44. KOHLA MA, El-Said H, El-Fert A, Ehsan N, et al
    Impact of nitazoxanide on sustained virologic response in Egyptian patients with chronic hepatitis C genotype 4: a double-blind placebo-controlled trial.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  45. NICOLINI LA, Menzaghi B, Ricci E, Martinelli C, et al
    Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role?
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  46. FUJIWARA K, Yasui S, Yokosuka O
    Appropriate diagnostic criteria for fulminant autoimmune hepatitis.
    Eur J Gastroenterol Hepatol. 2015;27:1230-1.
    PubMed     Text format    


  47. BASYIGIT S, Sapmaz F
    Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.
    Eur J Gastroenterol Hepatol. 2015;27:1230.
    PubMed     Text format    


  48. KESKIN O, Idilman R
    Sequential development of acute autoimmune hepatitis may lead to a serious clinical picture in primary biliary cirrhosis.
    Eur J Gastroenterol Hepatol. 2015;27:1228-9.
    PubMed     Text format    


    September 2015
  49. EMINLER AT, Ayyildiz T, Irak K, Kyc M, et al
    AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


    August 2015
  50. RUDLER M, Thibault V, Mouri S, Akhavan S, et al
    Hepatitis E infection in patients with severe alcoholic hepatitis: is there a place for systematic screening?
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  51. HAN SH, Suk KT, Kim DJ, Kim MY, et al
    Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  52. PANG Q, Bi JB, Xu XS, Liu SS, et al
    King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  53. SERRES L, Vasseur P, Tougeron D, Gand E, et al
    Cardiovascular events in chronic hepatitis C: prognostic value of liver stiffness evolution.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  54. BELLE A, Baumann C, Bigard MA, Zallot C, et al
    Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.
    Eur J Gastroenterol Hepatol. 2015;27:877-81.
    PubMed     Text format     Abstract available


  55. TRIPPOLI S, Fadda V, Maratea D, Messori A, et al
    Bayesian network meta-analysis to evaluate interferon-free treatments in naive patients with genotype 1 hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2015;27:983-4.
    PubMed     Text format    


    July 2015
  56. KHEDR MA, E Behairy B, Hussein ME, Marei AM, et al
    Monocyte-derived dendritic cells in children with chronic hepatitis C: correlation with interferon and ribavirin therapy.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  57. VERGARA M, Bejarano G, Dalmau B, Gil M, et al
    Usefulness of indirect noninvasive methods in predicting progression to cirrhosis in chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2015;27:826-833.
    PubMed     Text format     Abstract available


    June 2015
  58. ABDEL-GHAFFAR TY, Sira MM, Sira AM, Salem TA, et al
    Serological markers of autoimmunity in children with hepatitis A: relation to acute and fulminant presentation.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  59. PACOU M, Basso F, Gore C, Hass B, et al
    Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter?
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  60. MENDIZABAL M, Marciano S, Videla MG, Anders M, et al
    Fulminant presentation of autoimmune hepatitis: clinical features and early predictors of corticosteroid treatment failure.
    Eur J Gastroenterol Hepatol. 2015;27:644-648.
    PubMed     Text format     Abstract available


    May 2015
  61. OZARAS R, Tahan V, Ozbay G, Ozturk R, et al
    Hepatic apoptotic markers are not predictors for the virological response to interferon-based therapy in chronic hepatitis C patients.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  62. CHEN G, Liu H, Hu ZQ, Bai JH, et al
    A new scheme with infusion of hepatitis B immunoglobulin combined with entecavir for prophylaxis of hepatitis B virus recurrence among liver transplant recipients.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  63. OZEL BD, Poyrazoglu OK, Karaman A, Karaman H, et al
    The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  64. EL-ARABY HA, Ehsan NA, Konsowa HA, Abd-Elaati BM, et al
    Hepatic progenitor cells in children with chronic hepatitis C: correlation with histopathology, viremia, and treatment response.
    Eur J Gastroenterol Hepatol. 2015;27:561-9.
    PubMed     Text format     Abstract available


  65. HALFON P, Penaranda G, Mohamed S, Camus C, et al
    Nationwide large survey on hepatitis B surface antigen quantification use in real-life clinical practice.
    Eur J Gastroenterol Hepatol. 2015;27:557-60.
    PubMed     Text format     Abstract available


  66. CAUSSE X, Cadranel JF, Potier P, Hanslik B, et al
    Hepatogastroenterologists' knowledge of inactive carriers and immunotolerant hepatitis B virus patients in France: results of a practice survey.
    Eur J Gastroenterol Hepatol. 2015;27:544-9.
    PubMed     Text format     Abstract available


  67. ABDELFATTAH MR, Elsiesy H
    Reappraisal of upper age limit for adult living-donor liver transplantation using right lobe grafts: an outcome analysis.
    Eur J Gastroenterol Hepatol. 2015;27:593-9.
    PubMed     Text format     Abstract available


    April 2015
  68. GOVAN L, Wu O, Xin Y, Hutchinson SJ, et al
    Comparative effectiveness of antiviral treatment for hepatitis B: a systematic review and Bayesian network meta-analysis.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  69. EFE C, Cengiz M, Kahramanoglu-Aksoy E, Ylmaz B, et al
    Angiotensin-converting enzyme for noninvasive assessment of liver fibrosis in autoimmune hepatitis.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  70. CUI SB, Shu RH, Yan SP, Wu H, et al
    Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  71. BUYUKASIK NS, Buyukasik Y
    On status of serum iron parameters in chronic hepatitis and cirrhosis: comments on the article by Mao et al.
    Eur J Gastroenterol Hepatol. 2015;27:476.
    PubMed     Text format    


  72. ERCIN CN, Dogru T, Sertoglu E
    Neutrophil-to-lymphocyte ratio as a predictor of fibrosis in inactive hepatitis B carriers.
    Eur J Gastroenterol Hepatol. 2015;27:475-6.
    PubMed     Text format    


  73. EL-MEZAYEN HA, Habib S, Marzok HF, Saad MH, et al
    Diagnostic performance of collagen IV and laminin for the prediction of fibrosis and cirrhosis in chronic hepatitis C patients: a multicenter study.
    Eur J Gastroenterol Hepatol. 2015;27:378-85.
    PubMed     Text format     Abstract available


  74. SRIVASTAVA A, Mathias A, Yachha SK, Aggarwal R, et al
    Occult hepatitis B infection in children with chronic liver disease.
    Eur J Gastroenterol Hepatol. 2015;27:375-7.
    PubMed     Text format     Abstract available


  75. BELAY T, Woldegiorgis H, Gress T, Rayyan Y, et al
    Intrahepatic cholestasis of pregnancy with concomitant hepatitis C virus infection, Joan C. Edwards SOM, Marshall University.
    Eur J Gastroenterol Hepatol. 2015;27:372-4.
    PubMed     Text format     Abstract available


    March 2015
  76. POH Z, Goh BB, Chang PE, Tan CK, et al
    Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  77. OLIVA-MORENO J, Pena-Longobardo LM, Alonso S, Fernandez-Bolanos A, et al
    Labour productivity losses caused by premature death associated with hepatitis C in Spain.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  78. ZHANG L, Celentano DD, Le Minh N, Latkin CA, et al
    Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  79. IOANNOU GN, Bryson CL, Weiss NS, Boyko EJ, et al
    Associations between lipodystrophy or antiretroviral medications and cirrhosis in patients with HIV infection or HIV/HCV coinfection.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  80. RODRIGUES-PINTO E, Cardoso H, Coelho R, Andrade P, et al
    Higher aspartate aminotransferase platelet ratio index predicts early significant liver-related events in hepatitis C genotype 1 chronic liver disease.
    Eur J Gastroenterol Hepatol. 2015;27:361-2.
    PubMed     Text format    


    February 2015
  81. TAPAN S
    Assessment of the neutrophil to lymphocyte ratio in inactive hepatitis B carriers.
    Eur J Gastroenterol Hepatol. 2015;27:184-5.
    PubMed     Text format    


  82. KAYADIBI H, Sertoglu E, Uyanik M
    Which diagnostic tool for the prediction of intermediate liver fibrosis stages?
    Eur J Gastroenterol Hepatol. 2015;27:182.
    PubMed     Text format    


    January 2015
  83. YAN S, Wu H, Wang G, Chen Y, et al
    A new model combining the liver/spleen volume ratio and classification of varices predicts HVPG in hepatitis B patients with cirrhosis.
    Eur J Gastroenterol Hepatol. 2015.
    PubMed     Text format     Abstract available


  84. FLISIAK R, Halota W, Tomasiewicz K, Kostrzewska K, et al
    Forecasting the disease burden of chronic hepatitis C virus in Poland.
    Eur J Gastroenterol Hepatol. 2015;27:70-6.
    PubMed     Text format     Abstract available


  85. COBAN M, Sertoglu E
    Should the neutrophil-lymphocyte ratio be used as a noninvasive marker?
    Eur J Gastroenterol Hepatol. 2015;27:108.
    PubMed     Text format    


  86. MORIHARA D, Watanabe H, Takata K, Iwashita H, et al
    Adjusting the starting dose of telaprevir according to renal function decreases adverse effects and affects the sustained virological response rate.
    Eur J Gastroenterol Hepatol. 2015;27:55-64.
    PubMed     Text format     Abstract available


    December 2014
  87. BESTE LA, Green PK, Ioannou GN
    Boceprevir and telaprevir-based regimens for the treatment of hepatitis C virus in HIV/HCV coinfected patients.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  88. NAKAGAWA A, Atsukawa M, Tsubota A, Shimada N, et al
    Relationship between HCV dynamics and sustained virological responses in chronic hepatitis C genotype 1b patients treated with telaprevir-based triple therapy.
    Eur J Gastroenterol Hepatol. 2014;26:1329-34.
    PubMed     Text format     Abstract available


    November 2014
  89. MAO W, Hu Y, Lou Y, Chen Y, et al
    Abnormal serum iron markers in chronic hepatitis B virus infection may be because of liver injury.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  90. LI D, Gao G, Jiang H, Tang Z, et al
    Hepatitis B virus-associated glomerulonephritis in HBsAg serological-negative patients.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


    October 2014
  91. BUTI M, Morillas RM, Perez J, Prieto M, et al
    Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  92. KOLLER T, Kollerova J, Huorka M, Meciarova I, et al
    Noninvasive scoring algorithm to identify significant liver fibrosis among treatment-naive chronic hepatitis C patients.
    Eur J Gastroenterol Hepatol. 2014;26:1108-15.
    PubMed     Text format     Abstract available


  93. GRUNWALD D, Kothari D, Malik R
    Noninvasive markers in the assessment and management of autoimmune liver diseases.
    Eur J Gastroenterol Hepatol. 2014;26:1065-72.
    PubMed     Text format     Abstract available


    September 2014
  94. YLMAZ B, Aydn H, Can G, Senturk Z, et al
    The relationship between fibrosis level and blood neutrophil to lymphocyte ratio in inactive hepatitis B carriers.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  95. KARAGOZ E, Ulcay A, Tanoglu A, Kara M, et al
    Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  96. SERTOGLU E, Kayadibi H, Uyanik M
    Single parameter or index to predict liver injury?
    Eur J Gastroenterol Hepatol. 2014;26:1060.
    PubMed     Text format    


  97. TOPAL E, Catal F, Selimoglu MA, Karabiber H, et al
    Acquired atopic disease after liver transplantation in children; similarities to and differences from adults: a preliminary study.
    Eur J Gastroenterol Hepatol. 2014;26:1055-9.
    PubMed     Text format     Abstract available


    August 2014
  98. YEE BE, Nguyen NH, Zhang B, Vutien P, et al
    Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  99. LV N, Chu XD, Sun YH, Zhao SY, et al
    Analysis on the outcomes of hepatitis B virus perinatal vertical transmission: nested case-control study.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


  100. STAHMEYER JT, Rossol S, Bert F, Antoni C, et al
    Cost of treating hepatitis C in Germany: a retrospective multicenter analysis.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Abstract available


    April 2014
  101. WANG WL, Zhu Y, Cheng JW, Li MX, et al
    Major hepatectomy is safe for hepatocellular carcinoma in elderly patients with cirrhosis.
    Eur J Gastroenterol Hepatol. 2014;26:444-51.
    PubMed     Text format     Abstract available


    February 2014
  102. ERGUL B, Sarikaya M, Dogan Z, Filik L, et al
    Is liver biopsy a problem for patients on chronic hemodialysis?
    Eur J Gastroenterol Hepatol. 2014;26:241-2.
    PubMed     Text format    


    October 2013
  103. ABD ELRAZEK AE , Mahfouz HM, Metwally AM, El-Shamy AM, et al
    Mortality prediction of nonalcoholic patients presenting with upper gastrointestinal bleeding using data mining.
    Eur J Gastroenterol Hepatol. 2013.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: